LSD1/CoREST is an allosteric nanoscale clamp regulated by H3-histone-tail molecular recognition

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 31, 2012, Pages 12509-12514

  Baron, Riccardo ^a   Vellore, Nadeem A ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Chromatin remodeling; Computer simulation; Epigenetics; Pharmacology; Protein dynamics

Indexed keywords

COREPRESSOR PROTEIN; HISTONE H3; LYSINE SPECIFIC DEMETHYLASE 1; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION;

ALLOSTERIC REGULATION; ALLOSTERIC SITE; AMINO ACID MOTIFS; CHROMATIN; CRYSTALLOGRAPHY, X-RAY; HISTONE DEMETHYLASES; HISTONES; METHYLATION; MULTIPROTEIN COMPLEXES; NERVE TISSUE PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, QUATERNARY; PROTEIN STRUCTURE, TERTIARY; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84864497997     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1207892109     Document Type: Article

References (40)

1. Botrugno OA, Santoro F, Minucci S (2009) Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer. Cancer Lett 280:134-144.
2. Janzen WP, Wigle TJ, Jin J, Frye SV (2010) Epigenetics: Tools and technologies. Drug Discov Today Technol 7:e59-e65.
3. Hayami S, et al. (2011) Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int J Cancer 128:574-586.
4. Kahl P, et al. (2006) Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res 66:11341-11347. (Pubitemid 46009965)
5. Lim S, et al. (2010) Lysine-specific demethylase 1 (LSD1) is highly expressed in ERnegative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 31:512-520.
6. Schulte JH, et al. (2009) Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: Implications for therapy. Cancer Res 69:2065-2071.
7. Cho H-S, et al. (2011) Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells. Cancer Res 71:655-660.
8. Singh MM, et al. (2011) Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors. Neurooncology 13:894-903.
9. Hu X, et al. (2009) LSD1-mediated epigenetic modification is required for TAL1 function and hematopoiesis. Proc Natl Acad Sci USA 106:10141-10146.
10. Wang Y, et al. (2009) LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 138:660-672.
11. Kooistra SM, Helin K (2012) Molecular mechanisms and potential functions of histone demethylases. Nat Rev Mol Cell Biol 13:297-311.
12. Schenk T, et al. (2012) Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat Med 18:605-611.
13. Culhane JC, Cole PA (2007) LSD1 and the chemistry of histone demethylation. Curr Opin Chem Biol 11:561-568. (Pubitemid 47588999)
14. Rotili D, Mai A (2011) Targeting histone demethylases: A new avenue for the fight against cancer. Genes Cancer 2:663-679.
15. Forneris F, Binda C, Battaglioli E, Mattevi A (2008) LSD1: Oxidative chemistry for multi-faceted functions in chromatin regulation. Trends Biochem Sci 33:181-189.
16. Forneris F, Binda C, Vanoni M, Battaglioli E (2005) Human histone demethylase LSD1 reads the histone code. J Biol Chem 280:41360-41365. (Pubitemid 41832193)
17. Mosammaparast N, Shi Y (2010) Reversal of histone methylation: Biochemical and molecular mechanisms of histone demethylases. Annu Rev Biochem 79:155-179.
18. Shi Y (2007) Histone lysine demethylases: Emerging roles in development, physiology and disease. Nat Rev Genet 8:829-833.
19. Shi Y, et al. (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:941-953. (Pubitemid 40037608)
20. Forneris F, Binda C, Vanoni M, Mattevi A (2005) Histone demethylation catalysed by LSD1 is a flavin-dependent oxidative process. FEBS Lett 579:2203-2207. (Pubitemid 40469693)
21. Chen Y, et al. (2006) Crystal structure of human histone lysine-specific demethylase 1 (LSD1). Proc Natl Acad Sci USA 103:13956-13961. (Pubitemid 44452964)
22. Baron R, Binda C, TortoriciM, McCammon JA, Mattevi A (2011) Molecular mimicry and ligand recognition in binding and catalysis by the histone demethylase LSD1-CoREST complex. Structure 19:212-220.
23. Forneris F, Binda C, Adamo A, Battaglioli E, Mattevi A (2007) Structural basis of LSD1-CoREST selectivity in histone H3 recognition. J Biol Chem 282:20070-20074. (Pubitemid 47099979)
24. Yang M, et al. (2006) Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase. Mol Cell 23:377-387. (Pubitemid 44128856)
25. Stavropoulos P, Blobel G, Hoelz A (2006) Crystal structure and mechanism of human lysine-specific demethylase-1. Nat Struct Mol Biol 13:626-632. (Pubitemid 44036473)
26. Yang M, et al. (2007) Structural basis of histone demethylation by LSD1 revealed by suicide inactivation. Nat Struct Mol Biol 14:535-539. (Pubitemid 46871816)
27. Lin Y, et al. (2010) The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1. EMBO J 29:1803-1816.
28. Baron R, Vellore NA (2012) LSD1/CoREST reversible opening-closing dynamics: Discovery of a nanoscale clamp for chromatin and protein binding. Biochemistry 51:3151-3153.
29. Barrallo-Gimeno A, Nieto MA (2009) Evolutionary history of the Snail/Scratch superfamily. Trends Genet 25:248-252.
30. Laurent B, et al. (2012) A short Gfi-1B isoform controls erythroid differentiation by recruiting the LSD1-CoREST complex through the dimethylation of its SNAG domain. J Cell Sci 125:993-1002.
31. Garcia AE (1992) Large-amplitude nonlinear motions in proteins. Phys Rev Lett 68:2696-2699.
32. Amadei A, Linssen AB, Berendsen HJC (1993) Essential dynamics of proteins. Proteins 17:412-425. (Pubitemid 23358549)
33. Hess B, Kutzner C, van Der Spoel D, Lindahl E (2008) GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput 4:435-447.
34. Oostenbrink C, Villa A, Mark AE, van Gunsteren WF (2004) A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6. J Comput Chem 25:1656-1676.
35. Berendsen HJC (1981) Interaction Models for Water in Relation to Protein Hydration, ed BE Pullman.
36. Åqvist J (1990) Ion water interaction potentials derived from free-energy perturbation simulations. J Phys Chem 94:8021-8024.
37. McLachlan AD (1979) Gene duplications in the structural evolution of chymotrypsin. J Mol Biol 128:49-79.
38. Grant BJ, Rodrigues APC, ElSawy KM, McCammon JA, Caves LSD (2006) Bio3d: An R package for the comparative analysis of protein structures. Bioinformatics 22:2695-2696. (Pubitemid 44642612)
39. Humphrey W, Dalke A, Schulten K (1996) VMD: Visual molecular dynamics. J Mol Graph 14:33-38. (Pubitemid 26152973)
40. Durrant JD, de Oliveira CAF, McCammon JA (2011) POVME: An algorithm for measuring binding-pocket volumes. J Mol Graph Model 29:773-776.